A
Astria Therapeutics, Inc. (ATXS)
NGM – Real vaqt narxi. Valyuta: USD
12.58
+12.58 (0.00%)
Yopilishda: Jan 22, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NGM – Real vaqt narxi. Valyuta: USD
12.58
+12.58 (0.00%)
Yopilishda: Jan 22, 2026, 4:00 PM EDT
Astria Therapeutics, Inc., biotexnologik kompaniya, Qo'shma Shtatlarda allergik va immunologik kasalliklar uchun davolash usullarini kashf qilish, ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Uning asosiy mahsulot nomzodi - navenibart, plazma kallikreinining monoklonal antitel inhibitori bo'lib, u irsiy angioedema (shish)ni davolash uchun 1b/2 bosqichli klinik sinovlarda. Kompaniya shuningdek, STAR-0310ni ishlab chiqmoqda, bu OX40 antagonistining monoklonal antitelidir va u atopik dermatitni davolash uchun klinik rivojlanish bosqichida bo'lib, bu teri to'sig'ining buzilishi va qichishish bilan bog'liq immun buzilishdir. Kompaniya ilgari Catabasis Pharmaceuticals, Inc. nomi bilan tanilgan edi va 2021-yil sentyabr oyida Astria Therapeutics, Inc. nomini o'zgartirdi. Astria Therapeutics, Inc. 2008-yilda ro'yxatga olingan va shtab-kvartirasi Boston, Massachusetsda joylashgan.
There is no data to display
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-02-02 | 15-12G | ef20064466_1512g.htm |
| 2026-01-23 | POS AM | ef20063733_posam.htm |
| 2026-01-21 | 8-K | tm263644d1_8k.htm |
| 2025-12-23 | 8-K | tm2534154d1_8k.htm |
| 2025-12-18 | DEFM14A | ny20061309x1_defm14a.htm |
| 2025-12-03 | 425 | ef20060538_425.htm |
| 2025-11-12 | 10-Q | atxs-20250930x10q.htm |
| 2025-10-14 | 425 | ef20057029_425.htm |
| 2025-08-12 | S-8 | tm2522936d1_s8.htm |
| 2025-08-06 | 8-K | tm2522358d1_8k.htm |